Location Cambridge, Cambridgeshire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
XavierXavier Jacq obtained his PhD from Louis Pasteur University in Strasbourg, France in 1997. He then carried out post-doctoral training at Columbia University, NY, USA in cancer biology. Following a first industry experience at Sanofi-Synthelabo, Xavier joined Hybrigenics in Paris as a project leader in 2002 where he became interested in
targeting the ubiquitin proteasome pathway in the oncology field. He is an inventor on multiple patents related to inhibitors of deubiquitylating enzymes and assays.
